Phase Forward to Participate in the SCDM Fall Conference and Oncology Clinical Trial Summit

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate in two industry events this month including the SCDM (Society for Clinical Data Management) Fall Conference, September 16-19, in Chicago, Illinois, and the Oncology Clinical Trial Summit, September 17-18 in Arlington, Virginia. At the SCDM Conference, Phase Forward will showcase its electronic data capture (EDC) and safety management technologies at booth # 229. At the Oncology Clinical Trial Summit, Andrea Valente, Vice President, North American Services, will co-present a workshop with Heather Wolff, Associate Director of Clinical Data Management, Millennium Pharmaceuticals, titled, "Improve Data Quality and Timeliness through Electronic Data Capture.” The workshop will take place on September 17 at 8:30 a.m. During the session, both Valente and Wolff will explore the latest strategies and new technologies available in EDC used to ensure a successful clinical trial for oncology, focusing on three key topics: bringing efficiency to complex study design, considerations for handling external data and approaches for effectively managing oncology trials. Additionally, Phase Forward will exhibit at the Oncology Clinical Trial Summit. Members of the media and analyst communities interested in speaking with Phase Forward at either event should contact Meghan Locke at CHEN PR at 781-672-3147 or mlocke@chenpr.com. For additional event information, please visit: www.cbinet.com/show_conference.cfm?confCode=PC07068&field=summary and http://www.scdm.org/events/Fall2007/. About Phase Forward Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm™), clinical data management (Clintrial™), clinical trials signal detection (CTSD™), strategic pharmacovigilance (WebVDME™ and Signal Management), adverse event reporting (Clintrace™) and applied data standards (WebSDM™). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 250 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, or FDA, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.